Acrivon Therapeutics, Inc.
ACRV$1.54▲ 1.99% 24h
Acrivon Therapeutics, Inc.ACRV$1.54
+$0.5703(+58.82%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$59.67M
P/E ratio
—
EPS (diluted)
$-2.02
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
—
Net income
$-77.91M
Net margin
—
Gross margin
—
Dividends & financials
Acrivon Therapeutics, Inc. (ACRV) reported revenue of — and net income of $-77.91M, or $-2.02 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.